We studied the urinary excretion of organic acids by normal human subjects in an ambulant normal population, chosen without conscious bias. Quantitative Metabolic diseases that manifest with an organic aciduria as the principal biochemical symptom are being increasingly recognized and detected, often in association with mental impairment of various degrees (1) (2) (3) . Measurement of urinary acidic metabolites is valuable in early detection and detailed study of such metabolic diseases (3) (4) (5) (6) and additionally has potential in the diagnosis of certain pediatric disorders (7).
Metabolic diseases that manifest with an organic aciduria as the principal biochemical symptom are being increasingly recognized and detected, often in association with mental impairment of various degrees (1) (2) (3) . Measurement of urinary acidic metabolites is valuable in early detection and detailed study of such metabolic diseases (3) (4) (5) (6) and additionally has potential in the diagnosis of certain pediatric disorders (7) .
Studies of this kind require reliable qualitative and quantitative information on the urinary excretion of acidic metabolites by normal subjects as a basis on which to compare the results obtained for patients. The preceding papers (8, 9) describe investigations into the identity of urinary acidic metabolites in selected individuals from normal populations by use of gas-chromatographic and mass-spectrometric methods and into the effects of diet and individual variations on the excretion rate and the nature of the metabolites excreted.
Here, we report results of a quantitative survey of a probably typical ambulant normal population for these metabolites.
Results for the low-molecular-weight C2-C5 aliphatic acids are reported elsewhere (10) for selected subjects from the present group.
Subjects and Materials
For the present purposes, a "normal" subject is defined as a person selected without conscious bias, who is engaged in his everyday activities and is on an unrestricted diet. The group included some with, for example, minor infections, bowel disturbances, and cardiac and rheumatic diseases; they were taking medications for the treatment of these disorders.
The subjects studied were derived from the general medical practice of one of us (J.T.H.) and were selected by complete households, i.e., all the members of each household participated.
Arbitrary age groups of 5-10, 10-15, 15-25, 25-35, 35-45,45-55, 55-65, and >65 years of age were chosen and each age group divided into male and female groups, giving a total of 16 groups. Twenty-five subjects per group were obtained. Additional groups of boys and girls in the age range <5 years were included in the survey. The overall age range studied was 1.5-83 years, with a total of 420 subjects being examined.
The first urine passed on arising in the morning was collected directly into urine collection bags and an aliquot was frozen at -70 #{176}C in a plastic universal container as soon as possible thereafter (generally less than 30 mm, never more than 140 mm). A further aliquot was used to assess the presence of any bacterial contamination or urinary tract infection by dip-slide testing and culture for 48 h, with subsequent bacteria counts. Frozen specimens were stored at -20 #{176}C for not more than two weeks before being transported to the laboratory packed in solid carbon dioxide (-70 #{176}C). Specimens arrived frozen and were stored at -40 #{176}C until thawed for analysis, the longest storage time being eight weeks from sampling to analysis. Treatment of a sample of pure distilled water by a similar procedure produced no artefacts on analysis such as may be introduced from plastic laboratory ware.
Methods
Aliquots of urine equivalent to 3.0 mg of creatinine were analyzed by the previously described methods (7, (11) (12) (13) , and results were treated by the data-handling system described (14) . Typical gas-chromatograms, the identification of the urinary acidic metabolites, and the limits of detection of the methods used are described elsewhere (8) . Components for which specific identifications have not been made and mixed component peaks are referenced by their gas-chromatographic retention times relative to n-tetracosane internal standard.
The results were quantitated by reference to ntetracosane internal standard in terms of nanograms relative peak area (RPA) per microgram of creatinine. Where the response factor of the particular component relative to n-tetracosane is unity, "ng RPA" is equal to actual nanograrns (14) . Overlaps between peaks-mean that the quantitative values for some components may be less accurate than others, and sOme minor components are totally obscured by larger peaks. In the latter cases, however, where a particular peak is given a definite identity, the named compound forms at least 75% of the composite peak and generally more than 85%. The tetronic acids are expressed as a composite figure. In the normal subjects studied here, erythronic acid formed 55 to 75% of the combined peak area and threonic formed the remainder.
We used graphic techniques (15) to assess the distributions of the observed values for each metabolite across the age ranges. Normal ranges were also assessed graphically by plotting the cumulative distributions on logarithmic probability paper.
Results
A preliminary study showed that there were no consistent effects of age or sex on the excretion of any of the metabolites, apart from a slight tendency for higher values to occur in the youngest and oldest age groups; this tendency almost certainly can be attributed to the lower creatinine excretion in these age grOup8. Glucuronic a RPA-peak area relative to n-tetracosane internal standard. When the response factor relative to n-tetracosane equals unity mg RPA are equal to actual mIlligrams of compound.
The metabolites in group 1 (Figure 1 ) mostly exhibited fairly symmetrical distributions, in logarithmic terms, often accompanied by a few very low values. An exception was citric acid, the distribution of which in log terms was skewed to the left (though still skewed to the right when plotted arithmetically). Table 1 shows normal limits for these metabolites, calculated so as to exclude 2.5% of the observed values at each end of the distributions.
Some of the distributions in group 2 (Figure 2 ) had most of the observations in the measurable range; with others most of the values were below the level of detection. In either case, there seems no point in giving a lower limit of normality, and the normal limits in Table  20 2 are calculated to exclude 5% of the observed values,
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all on the high side of the distributions. The distributions in group 3 ( Figure 3 ) show bi-45 modality and, again, only upper normal limits are given in Table 3 -these are calculated to exclude 5% of the whole population, not of the upper subpopulation 95 only. 6 The distributions in group 4 (Figure 4 ), on the other 60 hand, are so irregular that any kind of statistical summarization seems inappropriate. These metabolites are listed in Table 4 .
Bacteria counts after 48-h culture ranged from zero to 10 organisms, but in most (71%) of the specimens fewer than 10 organisms were found, and a third (22% of the total) of these were sterile. A further 20% of the specimens showed 10 organisms and only 9% showed 10 or more organisms. Those specimens in which bacteria counts exceeded 10 organisms did not show acidic metabolite values that were significantly different from those in the rest of the population studied, and we saw no metabolites not normally present. Similar results were found when we studied the excretion of volatile low-molecular-weight (C2-C5) aliphatic acids by selected individuals (10) .
Similarly, no specimens of urine from patients receiving medication for various disorders showed values of acidic metabolites that differed significantly from 
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We are indebted to the individual subjects for their cooperation in this survey, and to Mrs. Hary Hart for her help in its organization and execution. We greatly appreciate the help of our colleague, Dr. T. Meade, of the DHSS/MRC Epidemiology and Medical Care Unit. The illnesses, and drugs used in their treatment, and with the widest possible age range, and thereby comparable in these respects to the mentally subnormal (3) and other patients who may be examined for the presence of abnormal organic acidurias. However, it is important to ensure that the fit individuals who are included in the practice register, as well as those who visit the practitioner's office or clinic, are studied, and we have done this in the present work, with a completely unselective sampling system being used.
It is generally impracticable to make reliable complete 24-h urine collections from mentally retarded patients, very young children, or large numbers of ambulant normal subjects, and the use of the first urine sample passed on rising in the morning greatly facilitates the survey type of investigations in such groups of subjects and the routine investigation of acutely ill neonates for metabolic disease. The major inborn errors of metabolism that cause abnormal organic aciduria produce marked effects, either increasing the excretion of known metabolites by about 10-to 100-fold or causing the excretion of compounds that are not detectable in urine from normal -persons. Quantitation is possible by relating the urinary excretion of the metabolite under consideration to the urinary creatinine excretion, and approximate 24-h values may be obtained by using the published values for creatinine excretion by normal adults (16) or children (17) . Results achieved by such extrapolations are in accord with values reported elsewhere for specific metabolites (18) . The limitations of urinary creatinine as a reference compound must be considered, and assume greater importance when individual patients are studied in depth and when the significance of small changes in metabolite excretion have to be assessed. In these circumstances 24-h urine collections, where possible, are preferred.
Previous work in this area has generally concentrated on the excretion of a small number of compounds by relatively few subjects, in order to provide control data for the diagnosis of individual diseases. The present work is the first systematic quantitative study of the urinary excretion of those acidic metabolites measured by the described techniques in an unrestricted population, evenly divided by sex and age.
Our results show that the metabolites may be divided into four groups, depending on the frequency distribution of their excretion values. Groups 1 and 2 contained most of the major metabolites, and these were consistently excreted by the majority of subjects studied. The normal ranges of excretion given in Tables 1  and 2 enable the quantitative significance of the aldonic and deoxyaldonic acids to be assessed; on a molar basis these acids form 30-35% of the total organic acid excretion in the subjects studied. The distributions shown by the metabolites in Group 3 are of special interest in that their obvious biomodality raises the possibility of genetically-controlled polymorphisms, and this aspect of the data is currently being investigated.
The very irregular distribution in Group 4 suggests that these metabolites are likely to be of exogenous origin, and this is confirmed by the identities of several of them. 5-Hydroxymethyl-2-furoic acid and tartaric acid are of dietary origin (8) and benzoic acid is produced through bacterial action, these acids being excreted intermittently when sequential specimens are examined (9) . Similar considerations probably apply to other meLnbers of this group, although in specific metabolic diseases some may be excreted in unusually large amounts, owing to endogenous metabolic processes [for example, 2-oxoglutaric acid in disorders of triose metabolism (7, 13) ]. The results given here enable the definition of the normal ranges of acidic metabolite excretion in man to which results on patients whose clinical state suggests that their excretion values may be abnormal can be compared, as in the case of the recent survey of mentally subnormal populations (3) and patients with metabolic diseases manifesting as organic acidurias (5) (6) (7) .
